It all started with a routine ultrasound.
A slightly dilated bile duct. No pain, no symptoms. The doctor’s advice? “Let’s just keep an eye on it.”
Three months later, my father was diagnosed with a pancreatic duct tumor — one with a high likelihood of turning cancerous. Thankfully, it was caught early. What made that possible wasn’t luck — it was a comprehensive, high-resolution scan that revealed what routine checkups couldn’t.
Today, drawing from my father’s story, I want to dive deeper into a critical pillar of the Prime Life journey: the Baseline Overhaul Assessment, with a special focus on cancer screening.
This is both a personal reflection from my own Prime Life practice and a firsthand account of a true race against time.
Building the Baseline: More Than “No News Is Good News”
As I was digging into my own historical health data (see last article), I began setting up what I now call my Baseline Overhaul Assessment — a full-spectrum scan of both current illness and future risk.
In reality, there isn’t a single institution where you can get everything done in one place. It took me months of research, testing, and consultation to cobble together a near-complete assessment from multiple providers. It cost me a small fortune, and I had to draw blood more times than I care to count.
But the outcome?
I became, quite possibly, the most “digitally quantified” person in my entire circle.
Naturally, friends started asking: was it worth it?
Here’s my answer, as someone who went first — and fumbled plenty:
“The earlier you understand your body, the more leverage you gain. And when it comes to health, time isn’t money — it’s everything.”
What I’ve gone through might help others design a clearer, leaner protocol for their own baseline assessment. That, alone, is worth the effort.
When Something’s Wrong: The Disease Scan
The most urgent part of any baseline overhaul is to identify what’s already wrong — but not yet discovered.
This is what I call the Disease Scan. Its goal: spot undiagnosed issues and stratify them by severity.
- Level 1: Critical illness, immediate intervention required (e.g., cancer)
- Level 2: Confirmed pathology, needs active medical management (e.g., hypertension)
- Level 3: Early indicators, can be managed via lifestyle (e.g., benign cysts)
And among these, cancer screening is the most urgent and high-leverage step.
Cancer is second only to cardiovascular disease as a leading cause of death. And its lethality often depends not on whether it appears — but when it’s found. Catch it early, and many cancers are curable. Catch it late, and the costs — financial, physical, emotional — can be devastating.
Imaging: The Front Line of Cancer Screening
Cancer screening is a multi-tool effort. The typical trio includes:
- Biochemical panels to catch abnormal metabolic patterns
- Genetic sequencing to understand inherited risk
- Imaging to visualize organ-level changes
Among these, imaging remains the most direct and effective diagnostic tool. Some examples:
- Low-dose spiral CT is the gold standard for lung cancer
- Mammogram + ultrasound is the twin strategy for breast cancer
- Endoscopy/colonoscopy is crucial for gastrointestinal cancers — and allows polyp removal on the spot
- MRI (Magnetic Resonance Imaging) offers the highest soft-tissue resolution without radiation exposure
After comparing safety, coverage, and diagnostic value, I believe MRI should be a cornerstone of early cancer screening.
It beats ultrasound in accuracy, avoids the radiation risks of CT or mammograms, and AI tools are quickly boosting its speed and early-detection capacity.
While no one tool can do it all — lung, breast, and GI cancers still require CT/mammogram/endoscopy respectively — MRI can scan the most of the body with unparalleled clarity and safety.
My Own Imaging Experience
I underwent full-body MRI across multiple organ systems. The entire process took over an hour — lying still inside the machine’s droning tunnel. To complement it, I also did low-dose CT, ultrasound, and GI endoscopy — to catch what MRI might miss.
The results?
No Level 1 risks detected, consistent with the typical range for over 95% of healthy middle-aged individuals.
My first reaction was relief. But then came a strange doubt:
“I spent all this time and money… and found nothing*. Was it really worth it? Should I keep doing this in the future? If yes, how often?”*
It’s a fair question. After all, 95% of people will receive a clean result.
But it’s that remaining 5% — the invisible few — who hang in the balance.
And my father turned out to be one of them.
My Father’s Story: From a Dilated Bile Duct to the OR Table
Early last year, a routine ultrasound showed his bile duct was dilated — 8 to 10mm. Nothing alarming. “Let’s observe,” said the doctor.
But three months later, it had widened to 14mm.
That rate of change triggered concern. He went in for MRI and PET-CT scans. That’s when they found it: an IPMN tumor (intraductal papillary mucinous neoplasm) inside the pancreas.
It was blocking the pancreatic duct and compressing the bile duct — the cause of the initial dilation.
That diagnosis was both a blow — and a stroke of luck.
Ultrasound alone couldn’t have detected it. Without MRI or PET-CT, the IPMN would’ve gone unnoticed. Left to develop, it had a 60% chance of evolving into full-blown pancreatic cancer within three years.
Pancreatic cancer is the king of killers. It hides well, moves fast, and has almost no effective treatments. From diagnosis to death, it often takes just one or two years.
My father had undergone a liver transplant 21 years earlier. Operating again in that region was a high-risk gamble. But he successfully underwent a Whipple operation — one of the most complex abdominal surgeries in modern medicine.
Recovery was brutal. But my father endured. Today, he walks 9,000 steps a day and lives with near-normal quality.
This short summary doesn’t do justice to what we went through as a family. The anxiety. The fear. The decisions. But it showed me what early detection, expert care, and inner strength can accomplish.
And it showed me what could have been, had we acted even earlier.
A Quick Summary
- Illness, if present, must be addressed first. That’s the core priority.
- The Disease Scan should be part one of any baseline overhaul — stratify your risks and respond accordingly.
- Cancer screening is especially crucial. A comprehensive MRI scan should be considered a foundational tool, complemented by biochemical and genetic assessments where relevant.
- Always consult your physician for personalized plans and test frequency. This article is for educational purposes only.
One More Thing: Destiny Isn’t Found. It’s Made.
My father’s story shook me deeply.
He had no symptoms. Just a routine test, followed by a decision to investigate further. He didn’t freeze in fear. He weighed the risks, faced them head-on, and made a hard choice with clarity.
He passed through fire — and emerged with grace.
What I witnessed wasn’t just a medical journey. It was a way of living:
Face the unknown. Make the call. Accept the consequences — without flinching.
Afterward, my father said he still had much to learn. He said his emotions were turbulent, that he hadn’t handled everything well.
But to me, he showed exactly what strength looks like.
This experience didn’t just influence my thinking — it changed the way I practice Prime Life.
To me, there’s no greater leverage than knowing your body early and intervening decisively.
And that mindset itself? It’s one of the most powerful forms of spiritual practice I know.
